URG CFO Roger Smith Exercises 252,087 Options and Sells Shares
Roger L. Smith, Chief Financial Officer of Ur‑Energy Inc. (URG), executed option exercises and a contemporaneous sale on 09/24/2025.
Rhea-AI Filing Summary
Roger L. Smith, Chief Financial Officer of Ur‑Energy Inc. (URG), executed option exercises and a contemporaneous sale on 09/24/2025. He exercised 252,087 options at an exercise price of C$0.63 (US$0.4535 per share using the reported FX rate) to acquire 252,087 common shares and then sold those 252,087 shares at C$2.3366 (US$1.6819 per share). After these transactions, Mr. Smith beneficially owned 632,175 common shares directly and held an additional 252,087 shares underlying options exercisable through 11/13/2025, for total reported direct beneficial interests reflected as 884,262 prior to the sale and 632,175 following the sale. The option grant date was 11/13/2020 with vesting in three annual tranches.
Positive
- 252,087 options exercised at the reported exercise price (C$0.63 / US$0.4535 equivalent)
- Complete disclosure of FX conversion used to translate Canadian dollar amounts to US dollars
- Vesting history provided for the 11/13/2020 option grant (three tranches: 11/13/2021, 11/13/2022, 11/13/2023)
Negative
- 252,087 shares sold on 09/24/2025, reducing direct beneficial ownership from 884,262 to 632,175 shares
- No cash proceeds total disclosed in USD or CAD beyond per‑share sale price and FX conversion
Insights
TL;DR Insider exercised previously granted options and sold the resulting shares the same day, materially changing direct holdings.
Mr. Smith exercised 252,087 options granted on 11/13/2020 at C$0.63 per share (US$0.4535 equivalent) and sold the same 252,087 shares at C$2.3366 (US$1.6819 equivalent) on 09/24/2025. The reported transactions reduced his direct beneficial ownership from 884,262 shares to 632,175 shares. These are routine Section 16 disclosures of option exercise and sale; the filing documents exact quantities, prices, and FX conversion used. For investors, the key facts are the option grant details, exercisable/expiration timeline through 11/13/2025, and the immediate disposition of the exercised shares.
TL;DR Filing documents a standard insider exercise-and-sale with fully disclosed terms and vesting history.
The Form 4 shows the options were granted 11/13/2020 and vested in three equal tranches on 11/13/2021, 11/13/2022 and 11/13/2023. The report provides precise FX conversions used to translate Cdn$ prices to US$ equivalents. The submission is signed and dated 09/25/2025, meeting disclosure formalities. The filing contains no additional corporate actions or deviations from standard Section 16 reporting requirements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common share options (right to buy) | 252,087 | $0.00 | $0.00 |
| Exercise | Common Shares | 252,087 | $0.4535 | $114K |
| Sale | Common Shares | 252,087 | $1.6819 | $424K |
Footnotes (3)
- F1. The options were exercised and the shares were acquired at $0.63 Canadian dollars, $0.4535 U.S. dollars is the equivalent price pursuant to the exchange rate realized as of the transaction date (Cdn$1.00 = US$0.7198).
- F2. The shares were sold at $2.3366 Canadian dollars, $1.6819 U.S. dollars is the equivalent of the sales price pursuant to the exchange rate realized as of the transaction date (Cdn$1.00 = US$0.7198).
- F3. The 252,087 options were granted on 11/13/2020 and vested and became exercisable as follows: 84,029 on 11/13/2021; 84,029 on 11/13/2022; and 84,029 on 11/13/2023.
FAQ
What insider transactions did URG CFO Roger L. Smith report on 09/24/2025?
How did Mr. Smith's beneficial ownership change after the transactions?
When were the options that were exercised originally granted and how did they vest?
What exchange rate was used to convert Canadian dollars to U.S. dollars in this filing?
Are the exercised options still exercisable or do they expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.